About Index Trending news
Analyze
Top 50 Pricing
Ablynx

Ablynx

Ablynx

Ablynx is a biopharmaceutical company engaged in the discovery and development of NanobodiesĀ® for a range of serious human diseases.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding Show all
Post-IPO equity
$82,800,000
Grant
$2,808,275
Employees

Team size

200+
Locations
HQ
Headquarters
$82,800,000 Post-IPO equity
thepharmaletter

Ablynx raises $82.8 million through share offering